SCHEMBL9447276

SCHEMBL9447276

Cc1ccc(C(C(=O)O)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 3/20 0.50
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
KIF11 P52732 5/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 2/20 0.46
CYP1A2 P05177 2/20 0.45
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
PTGS2 P35354 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45520 0.86 CYP1A2 (0.56) KCNN4CES1MAPTCYP1A2KMT2A
Acetic Acid SCHEMBL28104273 0.84 KCNN4 (0.56) KCNN4CES2CES1MAPTCYP1A2
SCHEMBL28690553 0.84 SMN1; SMN2 (0.48) KCNN4KIF11SMN1; SMN2MAPTCYP1A2
SCHEMBL11522471 0.84 CYP1A2 (0.54) KCNN4CES1MAPTCYP1A2KMT2A
SCHEMBL10909643 0.84 CYP1A2 (0.54) KCNN4CES1MAPTCYP1A2KMT2A
SCHEMBL29282850 0.84 CYP1A2 (0.54) KCNN4CES1MAPTCYP1A2KMT2A
SCHEMBL10403424 0.84 CYP1A2 (0.54) KCNN4CES1MAPTCYP1A2KMT2A
SCHEMBL29559623 0.84 CYP1A2 (0.54) KCNN4CES1MAPTCYP1A2KMT2A
SCHEMBL7880822 0.84 CYP1A2 (0.54) KCNN4CES1MAPTCYP1A2KMT2A
SCHEMBL30541207 0.84 CYP1A2 (0.54) KCNN4CES1MAPTCYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5274104-A N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders ELF SANOFI, A FRENCH CORP. (FR) 1993-12-28 US disclosed